Novartis — Entity Dossier | Plocamium Intelligence

Novartis

ORG Health Care / Pharmaceuticals Momentum 17.2 NORMAL Primary: Spectral Shift

Novartis is a Swiss multinational pharmaceutical company and one of the world's largest drug manufacturers, with major operations in innovative medicines, generics, and oncology. The company actively pursues acquisitions and licensing deals to expand its therapeutic portfolio across multiple disease areas.

Novartis acquired next-gen PI3Kα inhibitor from Synnovation for $2B upfront (up to $3B total) for breast cancer treatment; investing $480M in China; facing competitive pressure from Merck's acquisition of Terns Pharmaceuticals' leukemia drug targeting Scemblix market

-0.29

PSI Score

17.2

Momentum

Confidence

Connections

PSI Intelligence

30-Day Trend

Signal Decomposition

Attention Cascade

-0.136

Narrative Drift

0.034

Spectral Shift

112.934

Sentiment-Momentum Divergence

0.000

Source Concentration

0.849

Peer Comparison

N/A

Sector Rank

+0.00

Peer Z-Score

Sector Percentile

Network Analysis

4 Degree Centrality

Centrality History

Entity	Weight	Status
Merck	8	STABLE
China	3	STABLE
DOD	2	STABLE
Ohio	1	STABLE

Article Coverage (0)

Date	Lane	Title

Request Access

Full PSI intelligence, network analysis, EDGAR filings, and predicted links require an access token.